Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $1.85 billion. The enterprise value is $1.41 billion.
| Market Cap | 1.85B |
| Enterprise Value | 1.41B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 61.36 million shares outstanding. The number of shares has increased by 21.63% in one year.
| Shares Outstanding | 61.36M |
| Shares Change (YoY) | +21.63% |
| Shares Change (QoQ) | +20.93% |
| Owned by Insiders (%) | 1.32% |
| Owned by Institutions (%) | 111.84% |
| Float | 40.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.35 |
| Forward PS | 33.23 |
| PB Ratio | 2.61 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.57, with a Debt / Equity ratio of 0.12.
| Current Ratio | 9.57 |
| Quick Ratio | n/a |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -735.15 |
Financial Efficiency
Return on equity (ROE) is -31.90% and return on invested capital (ROIC) is -22.30%.
| Return on Equity (ROE) | -31.90% |
| Return on Assets (ROA) | -24.00% |
| Return on Capital (ROIC) | -22.30% |
| Revenue Per Employee | $424,668 |
| Profits Per Employee | -$826,690 |
| Employee Count | 187 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.16% in the last 52 weeks. The beta is 2.26, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.26 |
| 52-Week Price Change | +28.16% |
| 50-Day Moving Average | 34.05 |
| 200-Day Moving Average | 28.67 |
| Relative Strength Index (RSI) | 38.35 |
| Average Volume (20 Days) | 610,046 |
Short Selling Information
The latest short interest is 10.14 million, so 16.53% of the outstanding shares have been sold short.
| Short Interest | 10.14M |
| Short Previous Month | 9.99M |
| Short % of Shares Out | 16.53% |
| Short % of Float | 25.26% |
| Short Ratio (days to cover) | 19.99 |
Income Statement
In the last 12 months, KYMR had revenue of $79.41 million and -$154.59 million in losses. Loss per share was -$2.51.
| Revenue | 79.41M |
| Gross Profit | 79.41M |
| Operating Income | -178.04M |
| Pretax Income | -154.59M |
| Net Income | -154.59M |
| EBITDA | -150.23M |
| EBIT | -154.38M |
| Loss Per Share | -$2.51 |
Balance Sheet
The company has $526.37 million in cash and $87.02 million in debt, giving a net cash position of $439.35 million or $7.16 per share.
| Cash & Cash Equivalents | 526.37M |
| Total Debt | 87.02M |
| Net Cash | 439.35M |
| Net Cash Per Share | $7.16 |
| Equity (Book Value) | 711.20M |
| Book Value Per Share | 11.59 |
| Working Capital | 481.12M |
Cash Flow
In the last 12 months, operating cash flow was -$98.45 million and capital expenditures -$37.87 million, giving a free cash flow of -$136.32 million.
| Operating Cash Flow | -98.45M |
| Capital Expenditures | -37.87M |
| Free Cash Flow | -136.32M |
| FCF Per Share | -$1.93 |
Margins
Gross margin is 100.00%, with operating and profit margins of -224.19% and -194.67%.
| Gross Margin | 100.00% |
| Operating Margin | -224.19% |
| Pretax Margin | -194.67% |
| Profit Margin | -194.67% |
| EBITDA Margin | -189.18% |
| EBIT Margin | -194.40% |
| FCF Margin | -171.66% |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.63% |
| Shareholder Yield | -21.63% |
| Earnings Yield | -8.34% |
| FCF Yield | -7.35% |
Analyst Forecast
The average price target for KYMR is $42.70, which is 41.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $42.70 |
| Price Target Difference | 41.30% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 22.85% |
| EPS Growth Forecast (5Y) | -4.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 6.32 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.32 |
| Piotroski F-Score | 3 |